Literature DB >> 2303992

Iron depletion or chelation reduces ischemia/reperfusion-induced edema in gerbil brains.

A Patt1, I R Horesh, E M Berger, A H Harken, J E Repine.   

Abstract

Since hydrogen peroxide (H2O2) can react with ferrous iron (FE++) to form the more toxic hydroxyl radical (OH) in vitro, and since H2O2 is generated brain xanthine oxidase (XO) during ischemia/reperfusion (I/R), we hypothesized that gerbils depleted of iron by dietary restriction or treated with iron chelators would be less susceptible to I/R injury. We found that gerbils fed a low iron diet for 8 weeks had decreased brain and serum iron levels, less neurologic deficits, and decreased brain edema after temporary unilateral carotid ligation (ischemia) and then reperfusion than gerbils fed a control standard iron diet. In addition, brains from gerbils treated with iron-free deferoxamine (an iron chelator), but not iron-loaded deferoxamine, had decreased (P less than .05) brain edema following ischemia and reperfusion. The results indicate that iron may contribute to cerebral ischemia/reperfusion damage.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2303992     DOI: 10.1016/0022-3468(90)90407-z

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  19 in total

1.  Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure.

Authors:  Olav Albert Christophersen
Journal:  Microb Ecol Health Dis       Date:  2012-02-01

2.  Antioxidant treatment prevents cognitive impairment and oxidative damage in pneumococcal meningitis survivor rats.

Authors:  Tatiana Barichello; Ana Lucia B Santos; Geovana D Savi; Jaqueline S Generoso; Paola Otaran; Cleonice M Michelon; Amanda V Steckert; Francielle Mina; Clarissa M Comim; Felipe Dal-Pizzol; João Quevedo
Journal:  Metab Brain Dis       Date:  2012-05-17       Impact factor: 3.584

3.  There is no contradiction between increased clinical risk with higher serum ferritin levels and protection by ferritin in vitro.

Authors:  J L Sullivan
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

Review 4.  Role of iron in ischemia-induced neurodegeneration: mechanisms and insights.

Authors:  Gillipsie Minhas; Shweta Modgil; Akshay Anand
Journal:  Metab Brain Dis       Date:  2014-03-11       Impact factor: 3.584

5.  Reperfusion injury following testicular torsion and detorsion in prepubertal rats.

Authors:  M L Blank; P J O'Neill; C K Steigman; L M Cobb; R A Wilde; P J Havenstein; I H Chaudry
Journal:  Urol Res       Date:  1993

6.  Treatment with the iron chelator, deferoxamine mesylate, alters serum markers of oxidative stress in stroke patients.

Authors:  Magdy Selim
Journal:  Transl Stroke Res       Date:  2009-12-10       Impact factor: 6.829

7.  Effects of deferoxamine on brain injury after transient focal cerebral ischemia in rats with hyperglycemia.

Authors:  Yingqi Xing; Ya Hua; Richard F Keep; Guohua Xi
Journal:  Brain Res       Date:  2009-07-23       Impact factor: 3.252

Review 8.  Iron deficiency anemia in heart failure.

Authors:  Natasha P Arora; Jalal K Ghali
Journal:  Heart Fail Rev       Date:  2013-07       Impact factor: 4.214

9.  Alzheimer's disease drug discovery targeted to the APP mRNA 5'untranslated region.

Authors:  Jack T Rogers; Jeffrey D Randall; Paul S Eder; Xudong Huang; Ashley I Bush; Rudolph E Tanzi; Amanda Venti; Sandra M Payton; Tony Giordano; Seiichi Nagano; Catherine M Cahill; Robert Moir; Debomoy K Lahiri; Nigel Greig; Satinder Singh Sarang; Steven R Gullans
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.